An overlap in the hypermethylated sites has been identified between TNBC and bladder cancer patients, spanning from +197 bases to +554 bases relative to the transcription start site (TSS) of CREB3L1 [33,51]. The gene discussed is CREB3L1; the disease is urinary bladder carcinoma.